Affinity Asset Advisors, LLC Kura Oncology, Inc. Transaction History

Affinity Asset Advisors, LLC

$579 Million
Q3 2024

A detailed history of Affinity Asset Advisors, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 687,785 shares of KURA stock, worth $6.15 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

687,785

Previous 650,000 5.81%

Holding current value

$6.15 Million

Previous $13.4 Million 0.42%

% of portfolio

2.32%

Previous 1.82%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$18.57 - $23.23 $701,667 - $877,745	37,785 Added 5.81%	687,785 $13.4 Million
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $1.41 Million - $1.85 Million	-80,492 Reduced 11.02%	650,000 $13.4 Million
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $7.23 Million - $12.7 Million	538,957 Added 281.39%	730,492 $15.6 Million
Q4 2023 Feb 13, 2024	SELL	$7.58 - $14.38 $5.04 Million - $9.56 Million	-665,000 Reduced 77.64%	191,535 $2.75 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $453,920 - $637,854	-53,782 Reduced 5.91%	856,535 $7.81 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $5.32 Million - $7.74 Million	553,030 Added 154.79%	910,317 $9.63 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $948,263 - $1.29 Million	88,540 Added 32.95%	357,287 $4.37 Million
Q4 2022 Feb 13, 2023	SELL	$11.23 - $16.9 $4.57 Million - $6.88 Million	-407,006 Reduced 60.23%	268,747 $3.34 Million
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $3.03 Million - $4.91 Million	-252,503 Reduced 27.2%	675,753 $9.23 Million
Q2 2022 Aug 12, 2022	BUY	$10.71 - $18.33 $44,007 - $75,317	4,109 Added 0.44%	928,256 $17 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $4.29 Million - $6.18 Million	364,147 Added 65.03%	924,147 $14.9 Million
Q4 2021 Feb 11, 2022	BUY	$12.22 - $19.57 $366,600 - $587,100	30,000 Added 5.66%	560,000 $7.84 Million
Q3 2021 Nov 12, 2021	BUY	$15.42 - $21.72 $1.62 Million - $2.28 Million	105,000 Added 24.71%	530,000 $9.93 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $1.25 Million - $1.79 Million	60,000 Added 16.44%	425,000 $8.86 Million
Q1 2021 May 14, 2021	BUY	$24.75 - $39.14 $2.6 Million - $4.11 Million	105,000 Added 40.38%	365,000 $10.3 Million
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $7.54 Million - $10.8 Million	260,000 New	260,000 $8.49 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Account

Affinity Asset Advisors, LLC Kura Oncology, Inc. Transaction History